These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
268 related articles for article (PubMed ID: 10172434)
1. Medical patents: how far can they go? Lewis JI Health Syst Rev; 1995; 28(5):22-5. PubMed ID: 10172434 [No Abstract] [Full Text] [Related]
2. Ethical issues in the patenting of medical procedures. American Medical Association, Council on Ethical and Judicial Affairs. Food Drug Law J; 1998; 53(2):341-51. PubMed ID: 10346690 [No Abstract] [Full Text] [Related]
3. Patenting medical procedures: a search for a compromise between ethics and economics. Gocyk-Farber B Cardozo Law Rev; 1997; 18():1527-67. PubMed ID: 12173633 [No Abstract] [Full Text] [Related]
4. The coming US patent opposition. Apple T Nat Biotechnol; 2005 Feb; 23(2):245-7. PubMed ID: 15696151 [No Abstract] [Full Text] [Related]
5. Are you stealing from other doctors? Lowes RL Med Econ; 1996 Mar; 73(5):195-6, 198-9, 203-4 passim. PubMed ID: 10172618 [No Abstract] [Full Text] [Related]
6. Patenting medical and surgical techniques: an ethical-legal analysis. Wear SE; Coles WH; Szczygiel AH; McEvoy A; Pegels CC J Med Philos; 1998 Feb; 23(1):75-97. PubMed ID: 9555635 [TBL] [Abstract][Full Text] [Related]
8. Shares in the human genome--the future of patenting DNA. Thomas SM; Hopkins MM; Brady M Nat Biotechnol; 2002 Dec; 20(12):1185-8. PubMed ID: 12454661 [No Abstract] [Full Text] [Related]
9. Patenting of pure surgical and other medical procedures. Medical community's response and need for a legislative solution. Coble YD; Ile M; Taylor MB J Fla Med Assoc; 1996 May; 83(5):329-31. PubMed ID: 8666970 [No Abstract] [Full Text] [Related]
11. A nail in the coffin for DNA sequence patents? Yamanaka M Nat Biotechnol; 2008 Oct; 26(10):1085-6. PubMed ID: 18846072 [No Abstract] [Full Text] [Related]
12. The case for patenting medical procedures. Garris JJ Am J Law Med; 1996; 22(1):85-108. PubMed ID: 8819597 [No Abstract] [Full Text] [Related]
14. Inter partes reexamination: a potentially useful approach to challenging invalid biotechnology patents. Derzko NM; Behringer JW Nat Biotechnol; 2003 Jul; 21(7):823-5. PubMed ID: 12833101 [No Abstract] [Full Text] [Related]
15. Impact of gene patenting on R&D and commerce. Stott M; Valentine J Nat Biotechnol; 2003 Jul; 21(7):729-31; author reply 731. PubMed ID: 12833081 [No Abstract] [Full Text] [Related]
16. Patents, patients, and public policy: an incomplete intersection at 35 U.S.C. Section 287(c). Ho CM Univ Calif Davis Law Rev; 2000; 33(3):601-75. PubMed ID: 16389678 [No Abstract] [Full Text] [Related]
17. Equivalents in biotechnology patents. Auer HE Nat Biotechnol; 2003 Mar; 21(3):329-31. PubMed ID: 12610574 [No Abstract] [Full Text] [Related]
18. Surpassing the material: the human rights implications of informed consent in bioprospecting cells derived from indigenous people groups. Wu AO Wash Univ Law Q; 2000; 78(3):979-1003. PubMed ID: 16273699 [No Abstract] [Full Text] [Related]
19. Four rebuffs for Cabilly. Waltz E Nat Biotechnol; 2008 Apr; 26(4):362. PubMed ID: 18392001 [No Abstract] [Full Text] [Related]